Government secures early access to those being developed by Novavax and Janssen
The UK government has reached agreements it says will give British citizens early access to 90m doses of two more potential Covid-19 vaccines.
The vaccines are being developed by the US biotech company Novavax and the pharmaceutical business Janssen, which is owned by Johnson & Johnson and has its headquarters in Belgium.
